title: Development of diabetes after gatifloxacin therapy.
authors.affiliation: School of Pharmacy Practice, Creighton University, Omaha, NE 68178, USA. jstading@ad.creighton.edu
authors.forename: Julie A
authors.initials: JA
authors.lastname: Stading
authors.forename: Alan W Y
authors.initials: AW
authors.lastname: Chock
authors.forename: Maryann Z
authors.initials: MZ
authors.lastname: Skrabal
authors.forename: Michele A
authors.initials: MA
authors.lastname: Faulkner
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose; D002481:Cellulitis / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D024841:Fluoroquinolones / Q000009:adverse effects* / Q000627:therapeutic use; D000077734:Gatifloxacin; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
chemical_list: D000900:Anti-Bacterial Agents; D001786:Blood Glucose; D024841:Fluoroquinolones; D000077734:Gatifloxacin